These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 13184225)

  • 21. The hemolytic effect of primaquine. XIV. Pentose metabolism in primaquine-sensitive erythrocytes.
    KELLERMEYER RW; CARSON PE; SCHRIER SL; TARLOV AR; ALVING AS
    J Lab Clin Med; 1961 Nov; 58():715-24. PubMed ID: 14454971
    [No Abstract]   [Full Text] [Related]  

  • 22. The hemolytic effect of primaquine. V. Primaquine sensitivity as a manifestation of a multiple drug sensitivity.
    DERN RJ; BEUTLER E; ALVING AS
    J Lab Clin Med; 1955 Jan; 45(1):30-9. PubMed ID: 13233625
    [No Abstract]   [Full Text] [Related]  

  • 23. The hemolytic effect of primaquine V. Primaquine sensitivity as a manifestation of a multiple drug sensitivity.
    Dern RJ; Beutler E; Alving AS
    J Lab Clin Med; 1981 Jun; 97(6):750-9. PubMed ID: 7229509
    [No Abstract]   [Full Text] [Related]  

  • 24. IN VIVO GENERATION OF H2O2 IN MOUSE ERYTHROCYTES BY HEMOLYTIC AGENTS.
    COHEN G; HOCHSTEIN P
    J Pharmacol Exp Ther; 1965 Jan; 147():139-43. PubMed ID: 14255158
    [No Abstract]   [Full Text] [Related]  

  • 25. Primaquine-induced hemolytic anemia: role of membrane lipid peroxidation and cytoskeletal protein alterations in the hemotoxicity of 5-hydroxyprimaquine.
    Bowman ZS; Morrow JD; Jollow DJ; McMillan DC
    J Pharmacol Exp Ther; 2005 Aug; 314(2):838-45. PubMed ID: 15840764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GENERATION OF HYDROGEN PEROXIDE IN ERYTHROCYTES BY HEMOLYTIC AGENTS.
    COHEN G; HOCHSTEIN P
    Biochemistry; 1964 Jul; 3():895-900. PubMed ID: 14214074
    [No Abstract]   [Full Text] [Related]  

  • 27. Modelling primaquine-induced haemolysis in G6PD deficiency.
    Watson J; Taylor WR; Menard D; Kheng S; White NJ
    Elife; 2017 Feb; 6():. PubMed ID: 28155819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemolytic effect of therapeutic drugs. Clinical considerations of the primaquine-type hemolysis.
    KELLERMEYER RW; TARLOV AR; BREWER GJ; CARSON PE; ALVING AS
    JAMA; 1962 May; 180():388-94. PubMed ID: 14454972
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experimental hemolytic anemia induced by hetero-antisera. III. Variations in the lactic acid content of erythrocytes].
    PIPITONE V; RUSSO R; DAILLY L
    Boll Soc Ital Biol Sper; 1959 Oct; 35():1271-2. PubMed ID: 14433155
    [No Abstract]   [Full Text] [Related]  

  • 30. Primaquine-induced hemolytic anemia: effect of 6-methoxy-8-hydroxylaminoquinoline on rat erythrocyte sulfhydryl status, membrane lipids, cytoskeletal proteins, and morphology.
    Bolchoz LJ; Morrow JD; Jollow DJ; McMillan DC
    J Pharmacol Exp Ther; 2002 Oct; 303(1):141-8. PubMed ID: 12235244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Aspartic-ketoglutaric transminase activity in the erythrocytes in the course of an experimental hemolytic anemia].
    BUDILLON G; DI SIMONE A
    Boll Soc Ital Biol Sper; 1959 Dec; 35():1637-8. PubMed ID: 13805628
    [No Abstract]   [Full Text] [Related]  

  • 32. [Rhodanese activity in the erythrocytes in the course of an experimental hemolytic anemia].
    DI SIMONE A; BUDILLON G
    Boll Soc Ital Biol Sper; 1959 Dec; 35():1634-6. PubMed ID: 13816490
    [No Abstract]   [Full Text] [Related]  

  • 33. Observations on the haemolytic effect of primaquine in 100 Ghanaian children.
    CHARLES LJ
    Ann Trop Med Parasitol; 1960 Dec; 54():460-70. PubMed ID: 13692485
    [No Abstract]   [Full Text] [Related]  

  • 34. [On the problem of involvement of the nuclear substance in the erythrocytes in experimental hemolytic anemias].
    KREIMER AIa
    Biull Eksp Biol Med; 1960 Mar; 49():35-8. PubMed ID: 14411891
    [No Abstract]   [Full Text] [Related]  

  • 35. Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline.
    Bolchoz LJ; Budinsky RA; McMillan DC; Jollow DJ
    J Pharmacol Exp Ther; 2001 May; 297(2):509-15. PubMed ID: 11303037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primaquine-induced hemolytic anemia: role of splenic macrophages in the fate of 5-hydroxyprimaquine-treated rat erythrocytes.
    Bowman ZS; Jollow DJ; McMillan DC
    J Pharmacol Exp Ther; 2005 Dec; 315(3):980-6. PubMed ID: 16099929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [ERYTHROCYTE LIFE SPAN AND DESTRUCTION IN HEMOLYTIC ANEMIA].
    STERNIERI E; TRALDI A; BALDINI E; TINCANI GP
    Minerva Nucl; 1963 Sep; 7():372-5. PubMed ID: 14094524
    [No Abstract]   [Full Text] [Related]  

  • 38. Observations on the effect of irradiation in chronic acquired hemolytic anemia exhibiting hemolytic activity for transfused erythrocytes.
    EVANS RS; DUANE RT
    Blood; 1947 Jan; 2(1):72-84. PubMed ID: 20278336
    [No Abstract]   [Full Text] [Related]  

  • 39. DRUG-INDUCED hemolytic anemia.
    J Am Med Assoc; 1955 May; 158(4):310. PubMed ID: 14367082
    [No Abstract]   [Full Text] [Related]  

  • 40. [A contribution to the problem of hemolytic anemia in hereditary elliptocytosis].
    PLENERT W; THIEMANN HH
    Z Kinderheilkd; 1963; 88():163-75. PubMed ID: 13944023
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.